Skip to main content
SpringerLink
Log in

TaqI HLA-B and -DRB RFLP analysis can predict disease in siblings of affected children with 21-hydroxylase deficiency

  • Original Investigations
  • Published:
Human Genetics Aims and scope Submit manuscript

Summary

The possibility of using TaqI restriction fragment length polymorphism (RFLP) analysis of the HLA-B locus and the HLA-DR-DQ subregions, flanking the 21-hydroxylase genes, for predicting disease in siblings of children with 21-hydroxylase deficiency was analyzed in 12 nuclear families with at least one affected child and a total of 18 at-risk off-spring. As part of the study allelic TaqI HLA-B RFLP patterns were determined in homozygous cell lines and families. The frequencies of individuals homozygous for TaqI allelic patterns of the different investigated HLA loci, each locus alone and in various combinations, were determined in 100 random controls. In all 12 families it was possible to make correct genetic diagnosis by the use of only one restriction enzyme, TaqI, and two locus-specific HLA cDNA probes, HLA-B and -DRB. In all families four haplotypes were obtained. Thus, affected siblings as well as carriers could be identified. Seven of the eight sibling pairs concordant for 21-hydroxylase deficiency had pairwise identical TaqI HLA-B-DRB-DQA-DQB haplotypes. The last disease-concordant sibling pair had inherited different haplotypes from their mother, who had nonclassical 21-hydroxylase deficiency. None of the ten healthy children shared both haplotypes with their affected sibling(s). Early prenatal suppression of the fetal adrenal cortex with fluorinated corticosteroids can prevent virilization of female fetuses with 21-hydroxylase deficiency. In most cases RFLP analysis of the 21-hydroxylase genes is not informative enough for prenatal diagnosis. Our results from the present retrospective family study indicate that TaqI HLA-B and -DRB RFP analysis will be a valuable tool for first trimester assessment of 21-hydroxylase deficiency. TagI HLA-B and -DRB RFLP analysis can be performed on DNA from chorionic villi biopsies obtained in the 8th week of pregnancy. Supplemented with sex determination, early withdrawal of prophylactic steroid therapy will thus be feasible when the mother carries a male or an unaffected female fetus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Amor M, Parker KL, Globerman H, New MI, White PC (1988) Mutation in the CYP21B gene (Ile-172→Asn) causes steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 85:1600–1604

    Google Scholar 

  • Bidwell JL (1988) DNA-RFLP-analysis and genotyping of HLA-DR and -DQ antigens. Immunol Today 9:18–23

    Google Scholar 

  • Bidwell JL, Bidwell EA, Savage DA, Middleton D, Klouda PT, Bradley BA (1988) A DNA-RFLP typing system which positively identifies serologically well-defined and ill-defined HLA-DR and -DQ alleles, including DRw10. Transplantation 45:640–646

    Google Scholar 

  • Carlsson B, Wallin J, Böhme J, Möller E (1987) HLA-DR-DQ haplotypes defined by restriction fragment length analysis — correlation to serology. Hum Immunol 20:95–113

    Google Scholar 

  • Carroll MC, Campbell RD, Porter RR (1985) Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci USA 82:521–525

    Google Scholar 

  • David M, Forest MG (1984) Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr 105:799–803

    Google Scholar 

  • Dunham I, Sargent CA, Trowsdale J, Campbell RD (1987) Molecular mapping of the human major histocompatibility complex by pulsed-field electrophoresis. Proc Natl Acad Sci USA 84:7237–7241

    Google Scholar 

  • Dupont B, Oberfield SE, Smithwick EM, Lee TD, Levine LS (1977) Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet II:1309–1312

    Google Scholar 

  • Evans MI, Chrousus GP, Mann DW, Larsen JW, Green I, McCluskey J, Loriaux L, Fletcher JC, Koons G, Overpeck J, Schulman JD (1985) Pharmacologic suppression of the fetal adrenal gland in utero. JAMA 253:1015–1020

    Google Scholar 

  • Globerman H, Amor M, Parker KL, New MI, White PC (1988) Nonsense mutation causing steroid 21-hydroxylase deficiency. J Clin Invest 82:139–144

    Google Scholar 

  • Grosse-Wilde H, Valentine-Thon E, Vögeler U, Passarge E, Lorenzen F, Sippell WG, Bidlingmaier F, Knorr D (1988) HLA-A,B,C,DR typing and 17-OHP determination for second trimester prenatal diagnosis of 21-hydroxylase deficient CAH. Prenat Diagn 8:131–143

    Google Scholar 

  • Gueux D, Fiet J, Couillin P, Raux-Demay M-C, Mornet E, Galons H, Villette J-M, Boué J, Dreux C (1988) Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia by simultaneous radioimmunoassay of 21-deoxycortisol and 17-hydroxyprogesterone in amnitoic fluid. J Clin Endocrinol Metab 66:534–537

    Google Scholar 

  • Gustafsson K, Wiman K, Emmoth E, Larhammar D, Böhme J, Hyldig-Nielsen JJ, Ronne H, Peterson PA, Rask L (1984) Mutation and selection in the generation of class II histocompatibility antigen polymorphism. EMBO J 3:1655–1661

    Google Scholar 

  • Haglund-Stengler B, Ritzén EM, Luthman H (1989) 21-hydroxylase deficiency: disease-causing mutations categorized by densitometry of 21-hydroxylase deoxyribonucleic acid fragments. J Clin Endocrinol Metab 70:43–48

    Google Scholar 

  • Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y (1986) Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci USA 83:2841–2845

    Google Scholar 

  • Higashi Y, Tanae A, Inoue H, Hiromasa T, Fujii-Kyriyama Y (1988) Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products. Proc Natl Acad Sci USA 85:7486–7490

    Google Scholar 

  • Killeen AA, Seelig S, Ulstrom RA, Orr HT (1988) Diagnosis of classical steroid 21-hydroxylase deficiency using an HLA-B locus-specific DNA probe. Am J Med Genet 29:703–712

    Google Scholar 

  • Koller BH, Sidwell B, Demars R, Orr HT (1984) Isolation of HLA locus-specific DNA probes from the 3′-untranslated region. Proc Natl Acad Sci USA 81:5175–5178

    Google Scholar 

  • Larhammar D, Schenning L, Gustafsson K, Wiman K, Claesson L, Rask L, Peterson PA (1982) Complete amino acid sequence of an HLA-DR antigenlike chain as predicted from the nucleotide sequence: similarities with immunoglobulin and HLA-A, -B and -C antigens. Proc Natl Acad Sci USA 79:3687–3691

    Google Scholar 

  • Miller WL, Levine LS (1987) Molecular and clinical advances in congenital adrenal hyperplasia. J Pediatr 111:1–17

    Google Scholar 

  • Morel Y, André J, Uring-Lambert B, Hauptmann G, Bétuel H, Tossi M, Forest MG, David M, Bertrand J, Miller WL (1989) Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia. J Clin Invest 83:527–536

    Google Scholar 

  • Mornet E, Boué J, Raux-Demay M, Couillin P, Oury JF, Dumex Y, Dausset J, Cohen D, Boué A (1986) First trimester prenatal diagnosis of 21-hydroxylase deficiency by linkage analysis to HLA-DNA probes and by 17-hydroxyprogesterone determination. Hum Genet 73:358–364

    Google Scholar 

  • New MI (1987) Basic and clinical aspects of congenital adrenal hyperplasia. J Steroid Biochem 27:1–7

    Google Scholar 

  • Olerup O, Hillert J, Fredrikson S, Olsson T, Kam-Hansen S, Möller E, Carlsson B, Wallin J (1989) Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 86:7113–7117

    Google Scholar 

  • Pang S, Pollack MS, Loo M, Green O, Nussbaum R, Clayton G, Dupont B, New MI (1985) Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab 61:89–97

    Google Scholar 

  • Pang S, Pollack MS, Marshall RN, Immken LD (1990) Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 322:111–115

    Google Scholar 

  • Ploegh HL, Orr HT, Strominger JL (1980) Molecular cloning of a human histocompatibility antigen cDNA fragment. Proc Natl Acad Sci USA 77:6081–6085

    Google Scholar 

  • Pollack MS, Maurer D, Levine LS, New MI, Pang S, Duchon M, Owens RP, Merkatz IR, Nitowsky HM, Sachs G, Dupont B (1979) Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) by HLA typing. Lancet I:1107–1109

    Google Scholar 

  • Rodriques NR, Dunham I, Yu CY, Carroll MC, Porter RR, Campbell RD (1987) Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J 6:1653–1661

    Google Scholar 

  • Schenning L, Larhammar D, Bill P, Wiman K, Jonsson A-K, Rask L, Peterson PA (1984) Both α and β chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domain. EMBO J 3:447–452

    Google Scholar 

  • Speiser PW, New MI, White PC (1988) Molecular genetic analysis of nonclassical steroid 21-hydroxylase deficiency associated with HLA-B14,DR1. N Engl J Med 319:19–23

    Google Scholar 

  • Thomsen M, Abbal M, Neugebauer M, Cambon-Thomsen A (1989) Recombinations in the HLA system. Tissue Antigens 33:38–40

    Google Scholar 

  • Wake CT, Long EO, Mach B (1982) Allelic polymorphism and complexity of the genes for HLA-DR beta-chain — direct analysis of DNA-DNA hybridization. Nature 300:372–374

    Google Scholar 

  • White PC, Grossberger D, Onufer BJ, Chaplin DD, New MI, Dupont B, Strominger JL (1985) Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sci USA 82:1089–1093

    Google Scholar 

  • White PC, New MI, Dupont B (1986) Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci USA 83:5111–5115

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for BioTechnology, Karolinska Institute, NOVUM, S-14152, Huddinge, Sweden

    Olle Olerup

  2. Department of Clinical Immunology, Karolinska Institute at Huddinge Hospital, S-14152, Huddinge, Sweden

    Olle Olerup

  3. Department of Clinical Genetics, Karolinska Hospital, S-10401, Stockholm, Sweden

    Holger Luthman & Barbro Haglund-Stengler

  4. Department of Pediatric Endocrinology, Karolinska Hospital, S-10401, Stockholm, Sweden

    E. Martin Ritzén & Barbro Haglund-Stengler

Authors
  1. Olle Olerup
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Holger Luthman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Martin Ritzén
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Barbro Haglund-Stengler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olerup, O., Luthman, H., Martin Ritzén, E. et al. TaqI HLA-B and -DRB RFLP analysis can predict disease in siblings of affected children with 21-hydroxylase deficiency. Hum Genet 85, 467–472 (1990). https://doi.org/10.1007/BF00194218

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00194218

Keywords

Search

Navigation